Advanced Biomedical Technologies, Inc.
ABMT · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Market Cap | $3,530 | $4,917 | $10,492 | $4,178 |
| - Cash | $5 | $37 | $202 | $6 |
| + Debt | $6,811 | $6,889 | $4,741 | $4,917 |
| Enterprise Value | $10,337 | $11,769 | $15,031 | $9,089 |
| Revenue | $271 | $171 | $124 | $12 |
| % Growth | 58.3% | 38.5% | 960.2% | – |
| Gross Profit | $222 | $93 | $72 | $4 |
| % Margin | 81.9% | 54.5% | 58.1% | 34.8% |
| EBITDA | -$166 | -$367 | -$283 | -$601 |
| % Margin | -61.3% | -214.6% | -228.7% | -5,158% |
| Net Income | -$515 | -$729 | -$672 | -$949 |
| % Margin | -190.2% | -426.1% | -543.7% | -8,139.5% |
| EPS Diluted | -0.007 | -0.01 | -0.01 | -0.01 |
| % Growth | 29.8% | -8.3% | 4% | – |
| Operating Cash Flow | -$735 | -$846 | $647 | -$743 |
| Capital Expenditures | $0 | -$52 | -$31 | -$19 |
| Free Cash Flow | -$735 | -$897 | $616 | -$761 |